Trial intelligence / Profile preview

Atorvastatin for bile acid diarrhoea

2025-521856-47-00Phase 4Completed

Sponsor
Gentofte Hospital
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of atorvastatin in Bile acid diarrhea (BAD) (2 arms), sponsored by Gentofte Hospital. Primary endpoint: Ratio of geometric mean C4 concentration. Started Sep 2025; status: completed.

02

Drugs

atorvastatin
03

Conditions

Bile acid diarrhea (BAD)

Beyond the preview

Go deeper on 2025-521856-47-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-521856-47-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call